Cardioprotective effects of deferoxamine in acute and subacute cardiotoxicities of doxorubicin: a randomized clinical trial

The Egyptian Heart Journal

Table 5 Correlation of duration of treatment and doxorubicin dose with echocardiography parameters

AaM late diastolic velocity at lateral annulus of mitral valve, AaS late diastolic velocity of septum, AaT late diastolic velocity at lateral annulus of tricuspid valve, AM late diastolic velocity of mitral valve, AT late diastolic velocity of tricuspid valve, EaM early diastolic velocity at lateral annulus of mitral valve, EaS early diastolic velocity of septum, EaT early diastolic velocity at lateral annulus of tricuspid valve, EDV End diastolic volume, EM early diastolic velocity of mitral valve, ET early diastolic velocity of tricuspid valve, E/AM early to late diastolic velocity of mitral valve, EF Ejection fraction, EM/EaM early diastolic velocity of mitral to early diastolic velocity at lateral annulus of mitral valve, ESV End-systole volume, FS Fraction shortening, IVSD Interventricular septal thickness in diastole, IVSS Interventricular septal thickness in systole, LVIDD Left ventricular internal dimension at end-diastole, LVIDS Left ventricular internal dimension at end systole, LVPWD Left ventricular posterior wall in diastole, LVPWS Left ventricular posterior wall in systole, PAT Pulmonary acceleration time, SM tissue Doppler systolic velocity of mitral valve, SS systolic velocity of septum, ST systolic velocity of tricuspid valve, SV Stroke volume